Bryan Zair represents publicly traded and privately held U.S., foreign, and multinational clients on a broad range of transactional and corporate matters, focusing primarily in the areas of M&A, joint ventures, strategic alliances, collaborations, and similar arrangements, as well as other complex commercial arrangements including licensing, distribution, technology transfer, development, and supply agreements. He also counsels clients on general corporate law matters, including corporate governance and compliance.
Bryan's transactional experience spans a wide range of industries, including manufacturing, chemicals, automotive, life sciences, biotechnology, renewable energy, health care, pharmaceuticals, information technology, and agriculture.
Bryan is author of the chapter Best Practices In Implementing Corporate Divestitures in Managing Corporate Divestiture Transactions (December 2013).
Blue Point Capital recapitalizes J. America
ITC Holdings to be acquired by Fortis for $11.3 billion
GfK sells animal and crop health division